Canada Pension Plan Investment Board Protagonist Therapeutics, Inc Transaction History

Canada Pension Plan Investment Board

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$25.57 - $44.88 $1.41 Million - $2.47 Million	-55,000 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$19.02 - $31.15 $1.05 Million - $1.71 Million	55,000 New	55,000 $1.43 Million
Q1 2020 May 13, 2020	SELL	$5.4 - $9.22 $1.35 Million - $2.31 Million	-250,000 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$4.69 - $13.45 $1.17 Million - $3.36 Million	250,000 New	250,000 $1.76 Million

195

58.7M

20.8K

109K

Ticker PTGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,084,100
Market Cap $2.21B
Description
Protagonist Therapeutics, Inc., a biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address hematology and blood disorders, and inflammatory and immunomodulatory diseases. It is developing rusfertide (PTG-300), an injectable hepcidin mimetic that is in Phase II clinical trials for the treatment of patients with...

Get notified when there are updates to the investment portfolio of Canada Pension Plan Investment Board, based on Form 13F filings with the SEC.

Stay updated on Canada Pension Plan Investment Board with notifications on news.